Stockhub

Aeolus Pharmaceuticals, Inc.: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

17 August 2022

  • curprev 03:2903:29, 17 August 2022 >Paris 1,087 bytes +1,087 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Aeolus Pharmaceuticals, Inc., a biopharmaceutical company, develops a platform of novel compounds for use in biodefense, fibrosis, oncology, infectious, and central nervous system diseases in the United States. The company develops a class of catalytic antioxidant compounds as medical countermeasures against nuclear, radiological, and chemical weapons, as well as for diseases and disorders of the respiratory system, central..."
Retrieved from "https://stockhub.co/research/Aeolus_Pharmaceuticals,_Inc."